Location: Home
  • search
  • go
  • Relate News
  • 4/22/2020China Likely to Pull Some Drugs Out of the NRDL Soon
  • 4/22/2020NMPA Publicizes List of Reference Formulations for Generic Drug Equiva...
  • 4/22/2020Innovent Biologics Announces USFDA Approval of Pemazyre (Pemigatinib)
  • 4/21/2020PwC: 2019 An Active Year in Chinese Pharma M&A
  • 4/21/2020New Report: Cascading Economic Impacts of the COVID-19 Outbreak in Chi...
  • 4/21/2020XiAn Janssen Launches Psoriasis Drug Tremfya (Geselkumab) in China
  • 4/21/2020BeiGene's sNDA for Tislelizumab in Combo with NSCLC Chemotherapy in Ch...
  • 4/21/2020Coronavirus Puts Big Pharma’s IP Regime to the Test
  • 4/20/2020IQVIA: Chinese Retail Pharmacy Sales Up 3.9% in 2019
  • 4/20/2020IQVIA: Urban Chinese Hospital Drug Market Up 9.4% in 2019
  • 4/20/2020Chi-Med's Surufatinib Granted US Fast Track Designations
  • 4/20/2020NH's DB6: Chinese OTC Drug Market Forecast 2019-2028
  • 4/17/2020Recent Executive Moves
  • 4/17/2020NMPA Publishes the List of Reference Formulations for Generic Drug Equ...
  • 4/17/2020AmCham Survey: Supply Chain Challenges for US Companies in China
  • 4/17/2020Dynavax and Sinovac Announce Collaboration to Develop a COVID-19 Vacci...
  • 4/16/2020Zai Lab Granted Priority Review of sNDA for ZEJULA (Niraparib) for Fir...
  • 4/16/2020Fosun Unit Receives Import Approval of Dova's CLD Drug Avatrombopag
  • 4/16/2020Chinese Patent Applications on Inventions for Pharmaceutical Use (The ...
  • 4/16/2020China to Experiment Internet Healthcare Expansion at Six Provincial Le...
  • 4/16/2020NMPA Publishes the List of Reference Formulations for Generic Drug Equ...
  • 4/16/2020CDE Solicits Public Comments for Clinical Research Guidelines for Pert...
  • 4/15/2020Active Motif Licenses Four Antibodies to BioRay
  • 4/15/2020Harbour BioMed Granted IND Approval to Begin Phase 2/3 Clinical Trial ...
  • 4/15/2020Chinese Investors Maintains Appetite for Biopharma and Medtech with Qi...
  • 4/15/2020Mabworks Snags $160M in Series C1, C2 Rounds
  • 4/15/2020Gilead's Remdesivir Studies for Covid-19 Halted in China
  • 4/15/2020Flexion Licenses ER Corticosteroid to Tainuo Pharma in China
  • 4/15/2020LEO Pharma Enters License Deal with Oneness Bio and Microbio for FB825...
  • 4/15/2020Uni-Bio Science, Sinopharm Weiqida and Suzhou Yingli Enter Partnership...
  • Page:256/790 Total number of articles:23678: [First][<<] [254] [255] [256] [257] [258] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group